Nifty

:

25683.30

Sensex

:

83576.24

-193.55 (-0.75%)
-604.72 (-0.72%)

Login

Nifty
Sensex

:
:

25683.30
83576.24

-193.55 (-0.75%)
-604.72 (-0.72%)

Blue Jet Healthcare Ltd.

Pharmaceuticals & Drugs

Rating :

72/99

BSE: 544009 | NSE: BLUEJET

Watchlist

NSE BSE

500.20

09-Jan-2026

Open
High
Low
Previous Close

512.65
512.65
497
512.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

313575
157164774.15
1027.8
497

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

8,688.02
24.66
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

8,487.09
0.24%
6.92

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
15.60
12.63

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
12.80
11.51

PAT CAGR (%)

10 Years
5 Years
3 Years

-
16.60
24.01

P:E (Median)

8 Years
5 Years
3 Years

-
-
43.47

P:BV (Average)

8 Years
5 Years
3 Years

-
-
8.86

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
30.13

Earnings Forecasts:

(Updated: 10-01-2026)

Description 2024 2025 2026 2027
Adj EPS 17.59 17.98 22.74 26.15
P/E Ratio 28.44 27.82 22.00 19.13
Revenue 1024.73 1126.03 1341.76 1512.47
EBITDA 377.73 396.21 482.04 547.22
Net Income 305.2 312.05 373.46 417.28
ROA 24.65 18.01 17.1 16.22
P/B Ratio 10.35 10.88 11.13 10.24
ROE 24.76 23.78 22.84
FCFF 428.48 133.09 251.85 676.93
FCFF Yield 5.27 1.64 3.1 8.32
Net Debt -1005.57 -856.8 -971.14 -1336.9
BVPS 48.35 45.96 44.93 48.87

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 165.48 208.26 -20.54% 354.76 162.90 117.78% 340.44 183.94 85.08% 318.38 166.76 90.92%
Expenses 110.53 138.77 -20.35% 233.76 118.64 97.03% 200.48 130.88 53.18% 194.37 112.18 73.27%
EBITDA 54.95 69.49 -20.92% 120.99 44.26 173.36% 139.97 53.07 163.75% 124.01 54.58 127.21%
EBIDTM 33.21% 33.37% 34.11% 27.17% 41.11% 28.85% 38.95% 32.73%
Other Income 24.27 12.07 101.08% 8.25 8.71 -5.28% 12.22 8.83 38.39% 13.24 6.75 96.15%
Interest 4.63 0.02 23,050.00% 0.69 0.03 2,200.00% 0.03 0.03 0.00% 0.02 0.04 -50.00%
Depreciation 5.87 4.62 27.06% 5.70 3.48 63.79% 4.95 7.72 -35.88% 4.75 7.85 -39.49%
PBT 68.73 76.92 -10.65% 122.86 49.47 148.35% 147.21 54.15 171.86% 132.49 43.70 203.18%
Tax 16.59 18.57 -10.66% 31.69 11.69 171.09% 37.12 14.50 156.00% 33.51 11.59 189.13%
PAT 52.14 58.35 -10.64% 91.17 37.78 141.32% 110.09 39.65 177.65% 98.98 32.11 208.25%
PATM 31.51% 28.02% 25.70% 23.19% 32.34% 21.56% 31.09% 19.25%
EPS 3.00 3.36 -10.71% 5.25 2.18 140.83% 6.35 2.29 177.29% 5.71 1.85 208.65%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 1,179.06 1,029.98 711.60 720.98 683.47 498.93 Net Sales Growth 63.34% 44.74% -1.30% 5.49% 36.99% Cost Of Goods Sold 538.65 461.23 314.40 335.96 287.45 169.45 Gross Profit 640.41 568.76 397.20 385.02 396.01 329.48 GP Margin 54.32% 55.22% 55.82% 53.40% 57.94% 66.04% Total Expenditure 739.14 652.25 482.37 501.89 434.20 292.08 Power & Fuel Cost - 24.84 24.56 32.99 27.25 19.91 % Of Sales - 2.41% 3.45% 4.58% 3.99% 3.99% Employee Cost - 61.00 53.19 41.90 33.03 28.95 % Of Sales - 5.92% 7.47% 5.81% 4.83% 5.80% Manufacturing Exp. - 45.08 34.21 35.44 64.61 53.37 % Of Sales - 4.38% 4.81% 4.92% 9.45% 10.70% General & Admin Exp. - 12.18 8.90 12.49 5.23 8.11 % Of Sales - 1.18% 1.25% 1.73% 0.77% 1.63% Selling & Distn. Exp. - 29.93 28.26 27.27 5.56 4.20 % Of Sales - 2.91% 3.97% 3.78% 0.81% 0.84% Miscellaneous Exp. - 18.01 18.86 15.85 11.08 8.07 % Of Sales - 1.75% 2.65% 2.20% 1.62% 1.62% EBITDA 439.92 377.73 229.23 219.09 249.27 206.85 EBITDA Margin 37.31% 36.67% 32.21% 30.39% 36.47% 41.46% Other Income 57.98 46.26 28.86 23.96 19.41 8.61 Interest 5.37 0.10 0.16 1.36 3.30 5.31 Depreciation 21.27 17.79 28.09 25.07 22.15 19.66 PBT 471.29 406.10 229.84 216.61 243.23 190.49 Tax 118.91 100.90 56.34 56.58 61.64 48.87 Tax Rate 25.23% 24.85% 25.60% 26.12% 25.34% 25.65% PAT 352.38 305.20 163.75 160.03 181.59 141.62 PAT before Minority Interest 352.38 305.20 163.75 160.03 181.59 141.62 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 29.89% 29.63% 23.01% 22.20% 26.57% 28.38% PAT Growth 109.89% 86.38% 2.32% -11.87% 28.22% EPS 20.31 17.59 9.44 9.22 10.47 8.16

Description TTM Mar 21
Net Sales - 498.93 Net Sales Growth - Cost Of Goods Sold - 169.45 Gross Profit - 329.48 GP Margin - 66.04% Total Expenditure - 292.88 Power & Fuel Cost - 19.91 % Of Sales - 3.99% Employee Cost - 28.95 % Of Sales - 5.80% Manufacturing Exp. - 53.37 % Of Sales - 10.70% General & Admin Exp. - 8.11 % Of Sales - 1.63% Selling & Distn. Exp. - 4.20 % Of Sales - 0.84% Miscellaneous Exp. - 8.87 % Of Sales - 1.78% EBITDA - 206.05 EBITDA Margin - 41.30% Other Income - 8.88 Interest - 5.31 Depreciation - 19.66 PBT - 189.96 Tax - 48.87 Tax Rate - 26.47% PAT - 138.42 PAT before Minority Interest - 135.79 Minority Interest - 2.63 PAT Margin - 27.74% PAT Growth - EPS - 7.98

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 1,133.11 845.22 681.49 521.54 339.82 Share Capital 34.69 34.69 34.69 34.69 9.91 Total Reserves 1,098.42 810.53 646.79 486.85 329.91 Non-Current Liabilities 28.51 7.66 6.70 17.33 33.35 Secured Loans 0.00 0.00 0.00 0.00 28.67 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 4.70 4.12 4.13 3.77 3.29 Current Liabilities 500.57 361.59 318.42 259.07 220.05 Trade Payables 89.05 30.30 53.78 56.55 59.53 Other Current Liabilities 33.75 50.55 38.66 32.35 46.12 Short Term Borrowings 0.00 0.00 0.00 0.00 7.13 Short Term Provisions 377.77 280.74 225.98 170.17 107.27 Total Liabilities 1,662.19 1,214.47 1,006.61 797.94 593.22 Net Block 300.29 171.94 151.04 156.48 138.92 Gross Block 420.87 275.57 230.56 214.58 176.03 Accumulated Depreciation 120.58 103.63 79.52 58.10 37.11 Non Current Assets 411.58 353.21 197.02 165.03 146.25 Capital Work in Progress 89.16 147.06 30.46 3.43 2.58 Non Current Investment 0.00 15.00 0.00 0.00 0.00 Long Term Loans & Adv. 21.75 18.98 15.34 5.02 4.66 Other Non Current Assets 0.39 0.24 0.17 0.10 0.08 Current Assets 1,250.61 861.26 809.59 632.70 446.97 Current Investments 186.69 235.49 189.28 93.77 36.84 Inventories 263.92 129.84 125.66 105.03 117.72 Sundry Debtors 349.53 176.93 239.38 227.44 144.00 Cash & Bank 119.79 84.71 65.63 87.66 70.45 Other Current Assets 330.68 15.49 18.13 8.21 77.97 Short Term Loans & Adv. 324.17 218.81 171.52 110.58 73.77 Net Current Assets 750.04 499.67 491.17 373.63 226.93 Total Assets 1,662.19 1,214.47 1,006.61 797.73 593.22

Description Mar 21
Shareholder's Funds 339.82 Share Capital 9.91 Total Reserves 329.91 Non-Current Liabilities 33.35 Secured Loans 28.67 Unsecured Loans 0.00 Long Term Provisions 3.29 Current Liabilities 220.04 Trade Payables 59.53 Other Current Liabilities 46.11 Short Term Borrowings 7.13 Short Term Provisions 107.27 Total Liabilities 593.21 Net Block 138.92 Gross Block 176.03 Accumulated Depreciation 37.11 Non Current Assets 146.24 Capital Work in Progress 2.58 Non Current Investment 0.00 Long Term Loans & Adv. 4.66 Other Non Current Assets 0.08 Current Assets 446.97 Current Investments 36.84 Inventories 117.72 Sundry Debtors 144.00 Cash & Bank 70.45 Other Current Assets 77.97 Short Term Loans & Adv. 73.77 Net Current Assets 226.93 Total Assets 593.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 45.76 241.26 141.56 146.42 134.61 PBT 406.10 220.09 216.61 243.23 190.49 Adjustment -8.50 19.08 17.81 6.74 17.03 Changes in Working Capital -262.80 13.17 -32.89 -75.96 -72.71 Cash after chg. in Working capital 134.80 252.34 201.53 174.00 134.81 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -89.04 -11.08 -59.98 -27.59 -0.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -35.18 -263.75 -147.25 -76.03 -56.03 Net Fixed Assets -87.40 -161.61 -43.01 -39.40 Net Investments 63.80 -61.21 -95.51 -56.93 Others -11.58 -40.93 -8.73 20.30 Cash from Financing Activity -18.56 -1.99 -4.24 -56.15 -27.50 Net Cash Inflow / Outflow -7.97 -24.48 -9.94 14.25 51.08 Opening Cash & Equivalents 40.95 65.44 75.37 61.13 10.05 Closing Cash & Equivalent 32.98 40.95 65.44 75.37 61.13

Description Mar 21
Cash From Operating Activity 129.28 PBT 184.66 Adjustment 17.55 Changes in Working Capital -72.73 Cash after chg. in Working capital 129.47 Interest Paid 0.00 Tax Paid -0.20 Other Direct Exp. Paid 0.00 Extra & Other Items 0.00 Cash From Investing Activity -50.73 Net Fixed Assets Net Investments Others Cash from Financing Activity -27.50 Net Cash Inflow / Outflow 51.05 Opening Cash & Equivalents 10.07 Closing Cash & Equivalent 61.13

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 65.32 48.73 39.29 30.07 19.59 ROA 21.22% 14.75% 17.74% 26.11% 23.87% ROE 30.85% 21.45% 26.60% 42.16% 41.67% ROCE 41.06% 28.85% 36.24% 54.01% 50.03% Fixed Asset Turnover 2.96 2.81 3.24 3.50 2.83 Receivable days 93.28 106.77 118.17 99.18 105.35 Inventory Days 69.77 65.53 58.39 59.48 86.12 Payable days 47.23 48.81 59.93 73.70 128.23 Cash Conversion Cycle 115.82 123.49 116.62 84.96 63.23 Total Debt/Equity 0.00 0.00 0.00 0.00 0.15 Interest Cover 4144.87 1368.05 160.39 74.71 36.89

Description Mar 21
Book Value (Rs.) 19.59 ROA 26.50% ROE 51.06% ROCE 56.68% Fixed Asset Turnover 3.31 Receivable days 96.02 Inventory Days 68.30 Payable days 120.13 Cash Conversion Cycle 44.18 Total Debt/Equity 0.15 Interest Cover 35.79

Annual Reports:

News Update:

Blue Jet Healthcare - Quarterly Results
5th Nov 2025, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback